Surgery May Worsen Knee Osteoarthritis, Study Says, so What Could Help?

Why It Matters

The findings challenge a long‑standing surgical norm, urging clinicians to reconsider meniscectomy’s role and potentially reduce unnecessary procedures that may hasten joint degeneration. This shift could lower healthcare costs and improve long‑term mobility for millions with knee osteoarthritis.

Key Takeaways

• Partial meniscectomy linked to higher pain and osteoarthritis over 10 years.
• Sham arthroscopy patients reported better function and less knee pain.
• Non-surgical options like PT, anti-inflammatories, injections show longer‑term benefits.
• Meniscus repair may be reserved for acute traumatic tears only.

Pulse Analysis

The new Finnish trial adds to a growing body of evidence that arthroscopic partial meniscectomy offers limited benefit for knee osteoarthritis. By following 200 patients for ten years, researchers observed that those who had the meniscus tissue removed experienced greater pain, reduced activity, and faster radiographic progression than participants who received a diagnostic arthroscopy without tissue excision. The study underscores that meniscal tears, especially in middle‑aged and older adults, are frequently asymptomatic and coexist with degenerative changes, making them poor targets for surgical correction.

Clinicians are now urged to pivot toward conservative management as first‑line therapy. Physical therapy, structured exercise programs, weight management, and anti‑inflammatory medications have demonstrated durable pain relief and functional gains. Intra‑articular injections—corticosteroids, hyaluronic acid, and platelet‑rich plasma—provide short‑term symptom control while preserving joint integrity. When surgery is contemplated, strict criteria such as a displaced or locked tear should be met, and patients must be counseled on the heightened risk of subsequent knee replacement after meniscectomy. This nuanced approach aligns treatment with the underlying biology of osteoarthritis rather than isolated structural findings.

The broader implication reflects a healthcare trend of re‑evaluating entrenched procedures through rigorous trials. As payers and providers prioritize value‑based care, unnecessary surgeries are likely to face tighter scrutiny. Ongoing research into biologic modifiers and regenerative therapies may eventually offer disease‑modifying options, but until then, the emphasis remains on evidence‑based, non‑operative strategies that safeguard long‑term joint health. Patients equipped with this knowledge can make informed decisions, potentially avoiding a surgery that could accelerate the very condition it aims to treat.